arrow_back Back Filing freshness 10-Q FY 2023 SEC EDGAR

VERDE BIO HOLDINGS, INC.

APHD
— Price unavailable
Energy ·Crude Petroleum & Natural Gas ·USCrude Petroleum & Natural Gas
13 Visible periods
19 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

VERDE BIO HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth None
Op. Margin —
ROIC -87.7% ↗
FCF / Share —
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0% —
Net Income Profit after all expenses
$-3.44M
↓ -3.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality ↑
74

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 53 quarters